EMA Approves EU-Wide Rx-to-OTC Switch Of Fortacin
Executive Summary
Premature ejaculation treatment Fortacin is set to become only the fifth drug to achieve an Rx-to-OTC switch through EMA's centralized procedure, expanding the burgeoning OTC men's sexual health category.
You may also be interested in...
Cipla Switches Fexofenadine For Hives From Rx-To-OTC Status In The UK
UK hives sufferers can now buy a specific OTC medicine for their condition thanks to a successful Rx-to-OTC switch from Cipla.
Fortacin Wins Commission Approval As Fifth EU-Wide Rx-To-OTC Switch
European Commission approval of Fortacin as OTC premature ejaculation treatment makes it only the fifth drug switched EU-wide through the centralized procedure.
European OTC Results Round-Up: Recordati, Ipsen and Venture Life
First-half 2020 financials from Italy's Recordati, France's Ipsen and the UK's Venture Life.